Composiciones, usos y métodos para el tratamiento de trastornos y enfermedades metabólicos

Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70. The invention relates to a fusion of fibroblast growth factor 19 (FGF19) and fibroblast growth factor 21 (FGF21) and its use in the treatment of hyperglycemic condition, insulin re...

Full description

Saved in:
Bibliographic Details
Main Authors LINDHOUT, Darrin, LING, Lei
Format Patent
LanguageSpanish
Published 12.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70. The invention relates to a fusion of fibroblast growth factor 19 (FGF19) and fibroblast growth factor 21 (FGF21) and its use in the treatment of hyperglycemic condition, insulin resistance, hyperinsulinemia, glucose intolerance, metabolic syndrome, obesity, undesirable body mass, nonalcoholic fatty liver disease (NAFLD) nonalcoholic steatohepatitis (NASH), atherosclerosis and related disorders.
AbstractList Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70. The invention relates to a fusion of fibroblast growth factor 19 (FGF19) and fibroblast growth factor 21 (FGF21) and its use in the treatment of hyperglycemic condition, insulin resistance, hyperinsulinemia, glucose intolerance, metabolic syndrome, obesity, undesirable body mass, nonalcoholic fatty liver disease (NAFLD) nonalcoholic steatohepatitis (NASH), atherosclerosis and related disorders.
Author LING, Lei
LINDHOUT, Darrin
Author_xml – fullname: LINDHOUT, Darrin
– fullname: LING, Lei
BookMark eNqNijsKwkAQQLfQwt8dxl5BjGD6ELE3pRDG7AQWdneWnbHwSNYeIRczigeweu_Bm5tJ5Egzc604JBbXuTFlA3dhgQeE4alsR02YEciDZlQMjqIyWPqkKOf4nSn2lANZtCQQSPE2vLzrWJZm2qMXWv24MOtT3VTnLSVuSRJ2FEnb-rI_HspdUTZNUfzzvAHhyT_p
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ES2748038TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_ES2748038TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 13:06:31 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ES2748038TT33
Notes Application Number: ES20120807786T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200312&DB=EPODOC&CC=ES&NR=2748038T3
ParticipantIDs epo_espacenet_ES2748038TT3
PublicationCentury 2000
PublicationDate 20200312
PublicationDateYYYYMMDD 2020-03-12
PublicationDate_xml – month: 03
  year: 2020
  text: 20200312
  day: 12
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies NGM Biopharmaceuticals, Inc
RelatedCompanies_xml – name: NGM Biopharmaceuticals, Inc
Score 3.2603307
Snippet Un péptido quimérico que comprende o consiste en SEQ ID NO:2, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:69, o SEQ ID NO:70. The invention relates to a fusion of...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title Composiciones, usos y métodos para el tratamiento de trastornos y enfermedades metabólicos
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200312&DB=EPODOC&locale=&CC=ES&NR=2748038T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1qFfWmVdH6wQrSk8Um2aS9BKFJShH6gUbpQSjdZAMFkxQ3RfxJnv0J_WPOLI160Vs2GzaZgdnZ2bz3FuBKYpZJnI6GDYomj4TRnAlstiPLkDxJDEMSG3kwdPqP_G5iTyowL7kwWif0TYsjYkRFGO-Fnq8XP5tYvsZWqhsxx1v5bS90_ca6OiaklWE2_K4bjEf-yGt4nouLquG9i8VXp2V1QmsDNnEV3Sb0V_DUJVLK4ndG6e3B1hgHy4p9qEhVgx2vPHitBtuD9f9uvFyHnjqAZ4rcnHYhSF3_mi1Vrtg7S1cfBVaWipGGN5MvjNRmZymxHHMWS2oS_jHTD0ti92H6m8VSsRQNFKtPtDdXh3DZC0Kv38TPnH67ZBo8lAaFlnUE1QxffQzMacVRLCLTtrjJ48gWQnA7MVtOjHOe5PIE6n-PU_-v8xR2yb2EvjLMM6gWr0t5jum4EBfakV_iPJOF
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB20ivWmVdH6tYL0ZLFJNjGXIDRJqdovNEoPQukmGyjYprgp4k_y7E_oH3NmadWL3rLZsMkMzM7O5r23AOcSs0zquBo2KKo8FkZ1KLB5FVuG5GlqGJLYyO2O03zkt327vwKjJRdG64S-aXFEjKgY4z3X8_X0ZxMr0NhKdSlGeCu7bkReUFlUx4S0MsxKUPfCXjfo-hXf93BR1bn3sPhya5YbWauwhitsl2T2w6c6kVKmvzNKYwvWezjYJN-GFalKUPSXB6-VYKO9-N-Nl4vQUzvwTJGb0S4EqetfsJnKFHtn4_lHjpWlYqThzeQLI7XZ4ZhYjhlLJDUJ_zjRD0ti92H6GyZSsTEaKOafaG-mduGsEUZ-s4qfOfh2ySB8WBoUWdYeFCb46n1gTi2JExGbtsVNnsS2EILbqVlzEpzzJJcHUP57nPJ_nadQbEbt1qB107k7hE1yNSGxDPMICvnrTB5jas7FiXbqF_Y1lnU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Composiciones%2C+usos+y+m%C3%A9todos+para+el+tratamiento+de+trastornos+y+enfermedades+metab%C3%B3licos&rft.inventor=LINDHOUT%2C+Darrin&rft.inventor=LING%2C+Lei&rft.date=2020-03-12&rft.externalDBID=T3&rft.externalDocID=ES2748038TT3